l carnitine and kidney disease literature on the treatment of vascular with l-carnitine Frontiers Cardiac metabolic remodelling in chronic – L-Carnitine and Chronic Kidney Disease:

However, it has limitations with regards to the standardised metrics for the haemodynamic parameters utilised, its diagnostic accuracy is challenged by false positive diagnosis due to confounding factors (e.g

PD-induced mice model was treated with BV2-metformin-loaded PLGA 3 times per week for 34 weeks

Proc Natl Acad Sci U S A (1988) 85:597680.10.1073/pnas.85.16.5976 2 ShimizuRYamamotoM

When cells are exposed to oxidative stress, Nrf2 is released from Keap1 and translocates to the nucleus, where it binds to the antioxidant response element ARE and activates the transcription of antioxidant enzymes

Furthermore, some research indicates that it may accelerate the recovery process in tendons, ligaments, and bones